Thermo Fisher Scientific Deferred Revenue Timing Percentage decreased by 1.9% to $0.53 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $0.52 to $0.53. Over 3 years (FY 2020 to FY 2023), Deferred Revenue Timing Percentage shows a downward trend with a -10.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests a stronger short-term revenue outlook, while a decrease may indicate a shift toward longer-term contract fulfillment.
This metric measures the proportion of total deferred revenue that is contractually obligated to be recognized as income...
Standard across companies with long-cycle manufacturing or subscription-based service models.
deferred_revenue_timing_percentage| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.74 | $0.76 | $0.59 | $0.59 | $0.58 | $0.57 | $0.55 | $0.57 | $0.56 | $0.53 | $0.53 | $0.51 | $0.52 | $0.52 | $0.54 | $0.54 | $0.53 |
| QoQ Change | — | +2.7% | -22.4% | +0.0% | -1.7% | -1.7% | -3.5% | +3.6% | -1.8% | -5.4% | +0.0% | -3.8% | +2.0% | +0.0% | +3.8% | +0.0% | -1.9% |
| YoY Change | — | — | — | — | -21.6% | -25.0% | -6.8% | -3.4% | -3.4% | -7.0% | -3.6% | -10.5% | -7.1% | -1.9% | +5.9% | +3.8% | +1.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.